DE2231665A1 - Neue propoxyphensalze - Google Patents
Neue propoxyphensalzeInfo
- Publication number
- DE2231665A1 DE2231665A1 DE2231665A DE2231665A DE2231665A1 DE 2231665 A1 DE2231665 A1 DE 2231665A1 DE 2231665 A DE2231665 A DE 2231665A DE 2231665 A DE2231665 A DE 2231665A DE 2231665 A1 DE2231665 A1 DE 2231665A1
- Authority
- DE
- Germany
- Prior art keywords
- alpha
- acid
- chloro
- salt
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 title claims description 31
- WIWQDBABYGRKEW-UHFFFAOYSA-N 3,4-dichlorobenzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=C(Cl)C(Cl)=C1 WIWQDBABYGRKEW-UHFFFAOYSA-N 0.000 claims description 21
- 239000002585 base Substances 0.000 claims description 21
- 229960004193 dextropropoxyphene Drugs 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 15
- HKCFHDMLRDLQSN-UHFFFAOYSA-N 4-chloro-3-methylbenzenesulfonic acid Chemical compound CC1=CC(S(O)(=O)=O)=CC=C1Cl HKCFHDMLRDLQSN-UHFFFAOYSA-N 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 6
- ZZKWWRXVSXCBIU-UHFFFAOYSA-N 2-chloro-5-methylbenzenesulfonic acid Chemical compound CC1=CC=C(Cl)C(S(O)(=O)=O)=C1 ZZKWWRXVSXCBIU-UHFFFAOYSA-N 0.000 claims description 5
- -1 Diphenyl-2-propionoxy-3-methyl-4-dimethylaminobutane Chemical compound 0.000 claims description 5
- 230000000202 analgesic effect Effects 0.000 claims description 5
- 230000000954 anitussive effect Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 3
- 229940124584 antitussives Drugs 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- QMQBBUPJKANITL-MYXGOWFTSA-N dextropropoxyphene hydrochloride Chemical compound [H+].[Cl-].C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 QMQBBUPJKANITL-MYXGOWFTSA-N 0.000 claims description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 2
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- AIXLZRHUNVRXTR-UHFFFAOYSA-M sodium;3,4-dichlorobenzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=C(Cl)C(Cl)=C1 AIXLZRHUNVRXTR-UHFFFAOYSA-M 0.000 claims 2
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 1
- 229940065347 propoxyphene hydrochloride Drugs 0.000 claims 1
- AFNUQOOLRVXMEC-UHFFFAOYSA-M sodium;5-chloro-2-methylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(Cl)C=C1S([O-])(=O)=O AFNUQOOLRVXMEC-UHFFFAOYSA-M 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- XLMALTXPSGQGBX-GCJKJVERSA-N dextropropoxyphene Chemical class C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 XLMALTXPSGQGBX-GCJKJVERSA-N 0.000 description 15
- 235000019640 taste Nutrition 0.000 description 14
- 239000000047 product Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000007900 aqueous suspension Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229940080296 2-naphthalenesulfonate Drugs 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- HLOVKYCIOYWDHV-UHFFFAOYSA-M sodium;2-chloro-5-methylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(Cl)C(S([O-])(=O)=O)=C1 HLOVKYCIOYWDHV-UHFFFAOYSA-M 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- MNURPFVONZPVLA-UHFFFAOYSA-N 2-chlorobenzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1Cl MNURPFVONZPVLA-UHFFFAOYSA-N 0.000 description 1
- INNITFXCYVRMIZ-UHFFFAOYSA-N 4-amino-3-methyl-1,2-diphenylbutan-2-ol Chemical class C1=CC=CC(=C1)CC(C1=CC=CC=C1)(C(C)CN)O INNITFXCYVRMIZ-UHFFFAOYSA-N 0.000 description 1
- RJWBTWIBUIGANW-UHFFFAOYSA-M 4-chlorobenzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=C(Cl)C=C1 RJWBTWIBUIGANW-UHFFFAOYSA-M 0.000 description 1
- OTIVVZBPDZOCBM-UHFFFAOYSA-N 5-chloro-2-methylbenzenesulfonic acid Chemical compound CC1=CC=C(Cl)C=C1S(O)(=O)=O OTIVVZBPDZOCBM-UHFFFAOYSA-N 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 241001443715 Fusarium oxysporum f. sp. conglutinans Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
- 239000007958 cherry flavor Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XLMALTXPSGQGBX-PGRDOPGGSA-N levopropoxyphene Chemical compound C([C@@](OC(=O)CC)([C@@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 XLMALTXPSGQGBX-PGRDOPGGSA-N 0.000 description 1
- 229960003221 levopropoxyphene Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- QMHNQZGXPNCMCO-UHFFFAOYSA-N n,n-dimethylhexan-1-amine Chemical compound CCCCCCN(C)C QMHNQZGXPNCMCO-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical class C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical class OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C219/22—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15812671A | 1971-06-29 | 1971-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2231665A1 true DE2231665A1 (de) | 1973-01-11 |
Family
ID=22566784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2231665A Pending DE2231665A1 (de) | 1971-06-29 | 1972-06-28 | Neue propoxyphensalze |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US3728379A (forum.php) |
| AR (1) | AR193273A1 (forum.php) |
| AT (1) | AT315821B (forum.php) |
| AU (1) | AU462738B2 (forum.php) |
| BE (1) | BE785517A (forum.php) |
| CA (1) | CA966844A (forum.php) |
| CH (1) | CH574391A5 (forum.php) |
| DD (1) | DD100242A5 (forum.php) |
| DE (1) | DE2231665A1 (forum.php) |
| DK (1) | DK136973B (forum.php) |
| ES (1) | ES404317A1 (forum.php) |
| FR (1) | FR2143893B1 (forum.php) |
| GB (1) | GB1392004A (forum.php) |
| HU (1) | HU165527B (forum.php) |
| IE (1) | IE36416B1 (forum.php) |
| IL (1) | IL39702A (forum.php) |
| NL (1) | NL7208708A (forum.php) |
| PH (1) | PH10960A (forum.php) |
| PL (1) | PL84890B1 (forum.php) |
| SE (1) | SE387937B (forum.php) |
| SU (1) | SU465786A3 (forum.php) |
| ZA (1) | ZA724042B (forum.php) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312970A (en) * | 1989-05-26 | 1994-05-17 | Mallinckrodt Specialty Chemicals Company | Method of preparing D-propoxyphene |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2728779A (en) * | 1952-12-03 | 1955-12-27 | Lilly Co Eli | Esters of substituted aminobutanes |
| US3065261A (en) * | 1960-12-14 | 1962-11-20 | Lilly Co Eli | Pharmaceutical salts |
| US3395146A (en) * | 1965-02-11 | 1968-07-30 | Warner Lambert Pharmaceutical | 4-substituted-2-benzhydryl-2-butanol derivatives |
-
1971
- 1971-06-29 US US00158126A patent/US3728379A/en not_active Expired - Lifetime
-
1972
- 1972-06-13 CA CA144,555A patent/CA966844A/en not_active Expired
- 1972-06-13 IE IE828/72A patent/IE36416B1/xx unknown
- 1972-06-13 ZA ZA724042A patent/ZA724042B/xx unknown
- 1972-06-16 PH PH13633A patent/PH10960A/en unknown
- 1972-06-16 IL IL39702A patent/IL39702A/xx unknown
- 1972-06-20 AT AT531772A patent/AT315821B/de not_active IP Right Cessation
- 1972-06-23 NL NL7208708A patent/NL7208708A/xx unknown
- 1972-06-26 DD DD163977A patent/DD100242A5/xx unknown
- 1972-06-27 ES ES72404317A patent/ES404317A1/es not_active Expired
- 1972-06-27 PL PL1972156308A patent/PL84890B1/pl unknown
- 1972-06-28 SU SU1804380A patent/SU465786A3/ru active
- 1972-06-28 GB GB3023372A patent/GB1392004A/en not_active Expired
- 1972-06-28 DE DE2231665A patent/DE2231665A1/de active Pending
- 1972-06-28 HU HUEI423A patent/HU165527B/hu unknown
- 1972-06-28 DK DK323372AA patent/DK136973B/da unknown
- 1972-06-28 BE BE785517A patent/BE785517A/xx unknown
- 1972-06-28 CH CH970072A patent/CH574391A5/xx not_active IP Right Cessation
- 1972-06-28 SE SE7208513A patent/SE387937B/xx unknown
- 1972-06-29 FR FR7223615A patent/FR2143893B1/fr not_active Expired
- 1972-06-29 AR AR242826A patent/AR193273A1/es active
- 1972-06-29 AU AU44085/72A patent/AU462738B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AR193273A1 (es) | 1973-04-11 |
| DK136973C (forum.php) | 1978-07-03 |
| IE36416B1 (en) | 1976-10-27 |
| FR2143893B1 (forum.php) | 1975-10-31 |
| AT315821B (de) | 1974-06-10 |
| CH574391A5 (forum.php) | 1976-04-15 |
| IE36416L (en) | 1972-12-29 |
| ZA724042B (en) | 1974-02-27 |
| US3728379A (en) | 1973-04-17 |
| CA966844A (en) | 1975-04-29 |
| IL39702A0 (en) | 1972-08-30 |
| IL39702A (en) | 1975-03-13 |
| FR2143893A1 (forum.php) | 1973-02-09 |
| AU462738B2 (en) | 1975-07-03 |
| AU4408572A (en) | 1974-01-03 |
| GB1392004A (en) | 1975-04-23 |
| PL84890B1 (forum.php) | 1976-04-30 |
| ES404317A1 (es) | 1975-06-01 |
| PH10960A (en) | 1977-10-13 |
| BE785517A (fr) | 1972-12-28 |
| NL7208708A (forum.php) | 1973-01-03 |
| SU465786A3 (ru) | 1975-03-30 |
| DD100242A5 (forum.php) | 1973-09-12 |
| SE387937B (sv) | 1976-09-20 |
| HU165527B (forum.php) | 1974-09-28 |
| DK136973B (da) | 1977-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69300913T2 (de) | Polymorph Terazosin und pharmazeutische Zusammenstellung. | |
| DE69311130T2 (de) | Arylpropionsäurederivat, verfahren zu seiner herstellung und seine verwendung als analgetikum | |
| DE2445584C3 (de) | L- bzw. DL-2-Methyl-3- (3', 4'-dihydroxyphenyl)-alanin-ester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| CH638513A5 (de) | Verfahren zur herstellung neuer 4-amino-4-arylcyclohexanonketale. | |
| DE2557497A1 (de) | Neue tryptophanderivate mit erhoehter wirkung auf das zentralnervensystem | |
| DE2439859A1 (de) | Verfahren zur herstellung von 3-(3,4dihydroxy-phenyl)-serin | |
| AT391688B (de) | Verfahren zur herstellung des neuen n-methyl-dglucamin-salzes von (+)-2-(2-fluor-4-biphenylyl)- propionsaeure | |
| DE2265138B2 (de) | Vincaminsäure-benzylester, dessen Salze mit Säuren, ein Verfahren zu ihrer Herstellung und pharmazeutische Mittel | |
| DE2724183C2 (de) | 2-(4-Isobutylphenyl)propionsäure-p-hydroxyphenylharnstoffester und Verfahren zu seiner Herstellung | |
| DE3204854C2 (de) | 2-Amino-3-(halogenbenzoyl)-methylphenylessigsäuren, deren Ester und Salze, pharmazeutische Zubereitungen, welche diese Verbindungen enthalten | |
| DD249700A5 (de) | Verfahren zur herstellung des r-allenstereoisomer von 16-phenoxy- und 16-substituierten phenoxyprostatrien-saeurederivaten | |
| AT390954B (de) | Verfahren zur herstellung des neuen (-)-1beta|thyl-1alpha-(hydroxymethyl)-1,2,3,4,6,7,12, 12b alpha-octahydroindolo(2,3-a) chinolizins und von dessen saeureadditionssalzen | |
| DE2231665A1 (de) | Neue propoxyphensalze | |
| DE60205504T2 (de) | Zitronensäure salz von einer therapeutischen verbindung und deren pharmazeutischen zusammensetzungen | |
| AT345781B (de) | Verfahren zur herstellung von neuen 3- aminomethyl-2-phenylbicyclo (2,2,2) octanen und -octenen sowie deren saeureadditionssalzen | |
| DE2724184C2 (de) | 2-(4-Isobutylphenyl)propionsäure-p-hydroxybenzaldehydsemicarbazonester und Verfahren zu seiner Herstellung | |
| DD158397A5 (de) | Verfahren zur herstellung von isophthalsaeurepicolylamidmonohydrat | |
| EP0214528A2 (de) | (+)-6-Chlor-5,10-dihydro-5-[(1-methyl-4-piperidinyl)acetyl]-11H-dibenzo[b,e][1,4]diazepin-11-on, seine Isolierung und Verwendung als Arzneimittel | |
| EP0253293B1 (de) | Neue Guanidiniumasparaginate | |
| DE3807595A1 (de) | Optisch aktive oxo-isoindolinyl-derivate und verfahren zu deren herstellung | |
| EP0061654A1 (de) | Vincamin-cyclamat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel | |
| DE2164988C3 (de) | 2,2-Diphenylcyclopropancarbonsäureesterderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| DE4419973A1 (de) | Monohydratform des (R)-2-Cycloheptylmethylaminomethyl-8-methoxy-chroman-hydrochlorids | |
| CH629803A5 (en) | Process for preparing a new alkaloid of the vincamine type and salts thereof | |
| DE2749075A1 (de) | Quaternaere 1-methyl-2-(phenothiazin- 10-yl)-aethylammoniumsalze und diese enthaltende arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHA | Expiration of time for request for examination |